Recently, chest computed tomography (CT) has shown utility for COVID-19 diagnosis. In this study, we developed Deep COVID DeteCT (DCD), a deep learning convolutional neural network (CNN) that uses the entire chest CT volume to automatically predict COVID-19 (COVID+) from non-COVID-19 (...
Reduce spread within your communities with Aria, the wearable AI system for the early detection of respiratory infections, tailored to fight COVID-19.
Detect, Inc. (previously known as Homodeus) is a rapidly growing health-tech company founded by award-winning scientist and serial entrepreneur, Dr. Jonathan Rothberg. Detect is focused on developing a simple, rapid, scalable, low-cost platform to test for COVID-19, and ultimately for any pa...
Getting a COVID-19 test could soon be as easy as breathing into a tube. A startup in Singapore has developed a new screening tool that can analyze people's breath to determine whether or not they are infected within a minute. The company hopes to get approval for comme...
AAA On August 14, 2022, the Federal Drug Administration (FDA)authorized the first breath test for COVID-19. The authorization is an important milestone for the current pandemic as testing methods continue to evolve. With a simple exhale, individuals could test positive for COVID in just three...
COVID-19 is a worldwide pandemic that poses serious health hazards. COVID-19’s diagnostic test sensitivity is restricted owing to specimen processing abnormalities. The discussed technique might be used in clinical practice as a computer-aided diagnosti
As PoST is an environmental test, rather than a clinical test, it is both non-invasive and less expensive that a traditional nasal swabbing PCR. This means not only is it suitable for rollout in lower-income countries, but it also removes the discomfort ofcurrent COVID-19 testing options, ...
COVID sniffing test. Credit: Dominique Grandjean The success rate per dog (i.e., the number of correct indications divided by the number of trials) ranged from 76% to 100%. The lower bound of the 95% confidence interval of the estimated success rate was most of the time higher than t...
The health ministry approved on Dec. 5 a test kit that can simultaneously detect COVID-19 and seasonal influenza as an over-the-counter (OTC) medical product.
Data from consumer smartwatches can improve the detection of COVID-19 when combined with symptom self-reporting, and can also detect the disease in pre-symptomatic individuals. This is a preview of subscription content, access via your institution Relevant articles Open Access articles citing this...